Her medical history was remarkable for diabetes mellitus (DM), which was reported as “partially controlled”, cardiovascular disease, and breast cancer (managed with surgery and chemotherapy 6 years prior; she had been receiving an aromatase inhibitor, which was discontinued 6 months prior). Here, CYP19A1 is linked to diabetes mellitus.